{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:03:58Z","timestamp":1789833838595,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["UN108-023"],"award-info":[{"award-number":["UN108-023"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Phospholipase A2 group VI (<jats:italic>PLA2G6<\/jats:italic>) mutations associated with neurodegeneration (PLAN) manifest as heterogeneous neurodegenerative disorders with variable ages of onset. The genotype-phenotype correlation is not well-established. We aim to describe three adult patients with PLAN and combined these data with results from previous studies to elucidate adult-onset <jats:italic>PLA2G6<\/jats:italic> phenotype-genotype correlations.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentations<\/jats:title>\n<jats:p>The first index patient presented with dystonia-parkinsonism starting at age 31\u2009years, accompanied by major depression and cognitive decline. Genetic analysis using targeted next generation sequencing (NGS) panel, Sanger sequencing, and segregation analyses revealed a compound heterozygous mutation, c.991G\u2009&gt;\u2009T (p.D331Y)\/c.1077G\u2009&gt;\u2009A (M358IfsX), in <jats:italic>PLA2G6<\/jats:italic>. The other two patients had levodopa-responsive, early-onset parkinsonism, starting in their late twenties. Both patients had homozygous c.991G\u2009&gt;\u2009T (p.D331Y) mutations in <jats:italic>PLA2G6.<\/jats:italic> Patient characteristics of our reported 3 cases were compared to those of 32 previously described (2008 to 2019) patients with adult-onset PLAN. Among the combined cohort of 35 patients with adult-onset PLAN, 14 had dystonia-parkinsonism, 17 had early-onset Parkinson\u2019s disease, 3 had hereditary spastic paraparesis, and one had ataxia. The c.991G\u2009&gt;\u2009T (p. D331Y) mutation was almost exclusively found in Chinese patients, suggesting a common founder effect. All patients with homozygous p.D331Y mutations had levodopa-responsive, early-onset PD (100%); while other mutations mostly led to dystonia-parkinsonism, ataxia, spasticity, and combine psychiatric comorbidities.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We showed that adult-onset PLAN could present as purely parkinsonism features, without brain iron accumulation, particularly patients with homozygous p.D331Y mutations. Compound heterozygous mutations, including heterozygous p.D331Y, produced heterogeneous phenotypes, without obvious levodopa responsiveness.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12883-020-01684-6","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T10:02:39Z","timestamp":1584439359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review"],"prefix":"10.1186","volume":"20","author":[{"given":"Yung-Tsai","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Lung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"1684_CR1","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3389\/fneur.2018.01100","volume":"9","author":"YP Guo","year":"2018","unstructured":"Guo YP, Tang BS, Guo JF. PLA2G6-associated Neurodegeneration (PLAN): review of clinical phenotypes and genotypes. Front Neurol. 2018;9:1100.","journal-title":"Front Neurol"},{"key":"1684_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.parkreldis.2018.10.013","volume":"61","author":"A Darling","year":"2019","unstructured":"Darling A, Aguilera-Albesa S, Tello CA, Serrano M, Tom\u00e1s M, Camino-Le\u00f3n R, et al. PLA2G6-associated neurodegeneration: new insights into brain abnormalities and disease progression. Parkinsonism Relat Disord. 2019;61:179\u201386.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ana.21415","volume":"65","author":"C Paisan-Ruiz","year":"2009","unstructured":"Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol. 2009;65:19\u201323.","journal-title":"Ann Neurol"},{"key":"1684_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/B978-0-444-63233-3.00019-1","volume":"147","author":"SJ Hayflick","year":"2018","unstructured":"Hayflick SJ, Kurian MA, Hogarth P. Neurodegeneration with brain iron accumulation. Handb Clin Neurol. 2018;147:293\u2013305.","journal-title":"Handb Clin Neurol"},{"key":"1684_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jfma.2019.07.017","volume":"119","author":"SP Fan","year":"2020","unstructured":"Fan SP, Lee NC, Lin CH. Clinical and electrophysiological characteristics of a type 1 sialidosis patient with a novel deletion mutation in NEU1 gene. J Formos Med Assoc. 2020;119:406\u201312.","journal-title":"J Formos Med Assoc"},{"key":"1684_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1212\/WNL.0b013e318221acd3","volume":"77","author":"CH Shi","year":"2011","unstructured":"Shi CH, Tang BS, Wang L, Lv ZY, Wang J, Luo LZ, et al. PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort. Neurology. 2011;77:75\u201381.","journal-title":"Neurology"},{"key":"1684_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.parkreldis.2015.01.012","volume":"21","author":"F Xie","year":"2015","unstructured":"Xie F, Cen Z, Ouyang Z, Wu S, Xiao J, Luo W. Homozygous p.D331Y mutation in PLA2G6 in two patients with pure autosomal-recessive early-onset parkinsonism: further evidence of a fourth phenotype of PLA2G6-associated neurodegeneration. Parkinsonism Relat Disord. 2015;21:420\u20132.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ajmg.b.32012","volume":"159B","author":"CS Lu","year":"2012","unstructured":"Lu CS, Lai SC, Wu RM, Weng YH, Huang CL, Chen RS, et al. PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:183\u201391.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1684_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.parkreldis.2018.02.010","volume":"49","author":"YJ Chen","year":"2018","unstructured":"Chen YJ, Chen YC, Dong HL, Li LX, Ni W, Li HF, et al. Novel PLA2G6 mutations and clinical heterogeneity in Chinese cases with phospholipase A2-associated neurodegeneration. Parkinsonism Relat Disord. 2018;49:88\u201394.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.parkreldis.2019.04.002","volume":"65","author":"Y Ji","year":"2019","unstructured":"Ji Y, Li Y, Shi C, Gao Y, Yang J, Liang D, et al. Identification of a novel mutation in PLA2G6 gene and phenotypic heterogeneity analysis of PLA2G6-related neurodegeneration. Parkinsonism Relat Disord. 2019;65:159\u201364.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1468-1331.2008.02356.x","volume":"16","author":"F Sina","year":"2009","unstructured":"Sina F, Shojaee S, Elahi E, Paisan-Ruiz C. R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family. Eur J Neurol. 2009;16:101\u20134.","journal-title":"Eur J Neurol"},{"key":"1684_CR12","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/mds.25160","volume":"27","author":"P Agarwal","year":"2012","unstructured":"Agarwal P, Hogarth P, Hayflick S, MacLeod P, Kuriakose R, McKenzie J, et al. Imaging striatal dopaminergic function in phospholipase A2 group VI-related parkinsonism. Mov Disord. 2012;27:1698\u20139.","journal-title":"Mov Disord"},{"key":"1684_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.parkreldis.2013.10.016","volume":"20","author":"T Virmani","year":"2014","unstructured":"Virmani T, Thenganatt MA, Goldman JS, Kubisch C, Greene PE, Alcalay RN. Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia. Parkinsonism Relat Disord. 2014;20:245\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.parkreldis.2015.01.001","volume":"21","author":"MC Malaguti","year":"2015","unstructured":"Malaguti MC, Melzi V, Di Giacopo R, Monfrini E, Di Biase E, Franco G, et al. A novel homozygous PLA2G6 mutation causes dystonia-parkinsonism. Parkinsonism Relat Disord. 2015;21:337\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5334\/tohm.289","volume":"6","author":"A Giri","year":"2016","unstructured":"Giri A, Guven G, Hanagasi H, Hauser AK, Erginul-Unaltuna N, Bilgic B, et al. PLA2G6 Mutations Related to Distinct Phenotypes: A New Case with Early-onset Parkinsonism. Tremor Other Hyperkinet Mov (N Y). 2016;6:363.","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"1684_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/cge.13008","volume":"92","author":"B Ozes","year":"2017","unstructured":"Ozes B, Karagoz N, Schule R, Rebelo A, Sobrido MJ, Harmuth F, et al. PLA2G6 mutations associated with a continuous clinical spectrum from neuroaxonal dystrophy to hereditary spastic paraplegia. Clin Genet. 2017;92:534\u20139.","journal-title":"Clin Genet"},{"key":"1684_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s10038-018-0519-7","volume":"64","author":"K Koh","year":"2019","unstructured":"Koh K, Ichinose Y, Ishiura H, Nan H, Mitsui J, Takahashi J, et al. PLA2G6-associated neurodegeneration presenting as a complicated form of hereditary spastic paraplegia. J Hum Genet. 2019;64:55\u20139.","journal-title":"J Hum Genet"},{"key":"1684_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13104-016-2102-7","volume":"9","author":"SA Bohlega","year":"2016","unstructured":"Bohlega SA, Al-Mubarak BR, Alyemni EA, Abouelhoda M, Monies D, Mustafa AE, et al. Clinical heterogeneity of PLA2G6-related parkinsonism: analysis of two Saudi families. BMC Res Notes. 2016;9:295.","journal-title":"BMC Res Notes"},{"key":"1684_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.parkreldis.2018.03.010","volume":"52","author":"M Rohani","year":"2018","unstructured":"Rohani M, Shahidi G, Vali F, Lang AE, Slow E, Gahl WA, et al. Oculogyric crises in PLA2G6 associated neurodegeneration. Parkinsonism Relat Disord. 2018;52:111\u20132.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR20","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/WNL.0b013e3181f73649","volume":"75","author":"H Yoshino","year":"2010","unstructured":"Yoshino H, Tomiyama H, Tachibana N, Ogaki K, Li Y, Funayama M, et al. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism. Neurology. 2010;75:1356\u201361.","journal-title":"Neurology"},{"key":"1684_CR21","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/mds.23617","volume":"26","author":"MA Bower","year":"2011","unstructured":"Bower MA, Bushara K, Dempsey MA, Das S, Tuite PJ. Novel mutations in siblings with later-onset PLA2G6-associated neurodegeneration (PLAN). Mov Disord. 2011;26:1768\u20139.","journal-title":"Mov Disord"},{"key":"1684_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.parkreldis.2015.01.010","volume":"21","author":"YJ Kim","year":"2015","unstructured":"Kim YJ, Lyoo CH, Hong S, Kim NY, Lee MS. Neuroimaging studies and whole exome sequencing of PLA2G6-associated neurodegeneration in a family with intrafamilial phenotypic heterogeneity. Parkinsonism Relat Disord. 2015;21:402\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.parkreldis.2017.05.014","volume":"41","author":"T Wirth","year":"2017","unstructured":"Wirth T, Weibel S, Montaut S, Bigaut K, Rudolf G, Chelly J, et al. Severe early-onset impulsive compulsive behavior and psychosis in PLA2G6-related juvenile Parkinson's disease. Parkinsonism Relat Disord. 2017;41:127\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR24","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1007\/s12035-018-1118-5","volume":"56","author":"CC Chiu","year":"2019","unstructured":"Chiu CC, Lu CS, Weng YH, Chen YL, Huang YZ, Chen RS, et al. PARK14 (D331Y) PLA2G6 causes early-onset degeneration of Substantia Nigra dopaminergic neurons by inducing mitochondrial dysfunction, ER stress, Mitophagy impairment and transcriptional Dysregulation in a Knockin mouse model. Mol Neurobiol. 2019;56:3835\u201353.","journal-title":"Mol Neurobiol"},{"key":"1684_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/mdc3.12319","volume":"4","author":"R Erro","year":"2017","unstructured":"Erro R, Balint B, Kurian MA, Brugger F, Picillo M, Barone P, et al. Early Ataxia and subsequent parkinsonism: PLA2G6 mutations cause a continuum rather than three discrete phenotypes. Mov Disord Clin Pract. 2017;4:125\u20138.","journal-title":"Mov Disord Clin Pract"},{"key":"1684_CR26","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/mds.23615","volume":"26","author":"L Ferini-Strambi","year":"2011","unstructured":"Ferini-Strambi L, Marelli S, Moccia M, Erro R, Ciacci C, Barone P. Malabsorption is uncommon in restless legs syndrome. Mov Disord. 2011;26:1767\u20138.","journal-title":"Mov Disord"},{"key":"1684_CR27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s13760-018-1003-z","volume":"119","author":"WA Kamel","year":"2019","unstructured":"Kamel WA, Al-Hashel JY, Abdulsalam AJ, Damier P, Al-Mejalhem AY. PLA2G6-related parkinsonism presenting as adolescent behavior. Acta Neurol Belg. 2019;119:621\u20132.","journal-title":"Acta Neurol Belg"},{"key":"1684_CR28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5334\/tohm.254","volume":"5","author":"S Karkheiran","year":"2015","unstructured":"Karkheiran S, Shahidi GA, Walker RH, Paisan-Ruiz C. PLA2G6-associated Dystonia-Parkinsonism: Case Report and Literature Review. Tremor Other Hyperkinet Mov (N Y). 2015;5:317.","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"1684_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/mds.26527","volume":"31","author":"C Marras","year":"2016","unstructured":"Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, et al. Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force. Mov Disord. 2016;31:436\u201357.","journal-title":"Mov Disord"},{"key":"1684_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.parkreldis.2017.01.005","volume":"37","author":"JP Michelis","year":"2017","unstructured":"Michelis JP, Hattingen E, Gaertner FC, Minnerop M, Tr\u00e4ber F, Biskup S, et al. Expanded phenotype and hippocampal involvement in a novel compound heterozygosity of adult PLA2G6 associated neurodegeneration (PARK14). Parkinsonism Relat Disord. 2017;37:111\u20133.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neulet.2012.02.078","volume":"514","author":"JY Tian","year":"2012","unstructured":"Tian JY, Tang BS, Shi CH, Lv ZY, Li K, Yu RL, et al. Analysis of PLA2G6 gene mutation in sporadic early-onset parkinsonism patients from Chinese population. Neurosci Lett. 2012;514:156\u20138.","journal-title":"Neurosci Lett"},{"key":"1684_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00702-016-1658-7","volume":"124","author":"C Yamashita","year":"2017","unstructured":"Yamashita C, Funayama M, Li Y, Yoshino H, Yamada H, Seino Y, et al. Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism. J Neural Transm (Vienna). 2017;124:431\u20135.","journal-title":"J Neural Transm (Vienna)"},{"key":"1684_CR33","doi-asserted-by":"publisher","first-page":"e12897","DOI":"10.1371\/journal.pone.0012897","volume":"5","author":"LA Engel","year":"2010","unstructured":"Engel LA, Jing Z, O'Brien DE, Sun M, Kotzbauer PT. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. PLoS One. 2010;5:e12897.","journal-title":"PLoS One"},{"key":"1684_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.parkreldis.2012.07.016","volume":"19","author":"YX Gui","year":"2013","unstructured":"Gui YX, Xu ZP, Wen L, Liu HM, Zhao JJ, Hu XY. Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease. Parkinsonism Relat Disord. 2013;19:21\u20136.","journal-title":"Parkinsonism Relat Disord"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01684-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-020-01684-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01684-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:07:15Z","timestamp":1615939635000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01684-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01684-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"21 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of National Taiwan University Hospital and all study participants gave their inform consents before entering the study. Our study is in accordance with the Declaration of Helsinki and CARE guidelines\/methodology. All authors agreed the Publish Statements of BMC Neurology.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from each of the participants in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no competing interests or conflicts of interest.Chin-Hsien Lin is a member of the editorial board (Associate Editor) of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}